Technology Intervention to Support Caregiving for Alzheimer's Disease (I-CARE)
I-CARE
2 other identifiers
interventional
53
1 country
2
Brief Summary
The specific aims of this study are 1) to test the trial and intervention feasibility of Brain Care Notes (BCN) app, 2) To estimate the effect size of BCN on reducing informal caregiver burden at 6 months, and 3) To estimate the effect size of BCN on reducing patient behavioral and psychological symptoms of dementia (BPSD) at 6 months. Subjects will be recruited from the Aging Brain Care (ABC) program of Eskenazi Health and Indiana University Health located in central Indiana.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2019
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 12, 2017
CompletedFirst Posted
Study publicly available on registry
April 18, 2017
CompletedStudy Start
First participant enrolled
November 25, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2021
CompletedResults Posted
Study results publicly available
September 19, 2024
CompletedSeptember 19, 2024
August 1, 2024
1.7 years
April 12, 2017
July 31, 2022
August 27, 2024
Conditions
Outcome Measures
Primary Outcomes (6)
Feasibility: Recruitment Rate
Recruitment rate is the average monthly rate of recruitment into the study, calculated as participants recruited over the accrual period.
15 month accrual period
Feasibility: Data Completeness
Data completeness is the number of enrolled and randomized individuals who provided data at 3 and 6 months.
6 months after enrollment and randomization
Feasibility: BCN Usability (3 Months)
BCN usability at 3 months is the summary score on the modified System Usability Scale (SUS) 10-item scale instrument, ranging from 0 (worst outcome) to 100 (best outcome).
3 months
Feasibility: BCN Usability (6 Months)
BCN usability at 6 months is the summary score on the modified System Usability Scale (SUS) 10-item scale instrument, ranging from 0 to 100. Higher scores indicate higher usability.
6 months
Feasibility: BCN Acceptance (3 Months)
Acceptance at 3 months is the mean score on the Behavioral Intention 4-item scale on a 7-point response scale from 0 (not at all) to 6 (a great deal). Higher scores indicate higher acceptance.
3 months
Feasibility: BCN Acceptance (6 Months)
Acceptance at 6 months is the mean score on the Behavioral Intention 4-item scale on a 7-point response scale from 0 (not at all) to 6 (a great deal).
6 months
Secondary Outcomes (8)
Caregiver Burden (Baseline)
baseline
Caregiver Burden (3 Months)
3 months
Caregiver Burden (6 Months)
6 months
BPSD Severity (Baseline)
baseline
BPSD Severity (3 Months)
3 months
- +3 more secondary outcomes
Study Arms (2)
ABC Clinical Program Only and Usual Care
ACTIVE COMPARATORPatients and informal caregivers randomized to the comparison group will receive care provided by the ABC Clinical Program and IUHP. The ABC Clinical Program is the standard of ADRD care at Eskenazi Health and Primary Care Visits at Indiana University Health is the usual care.
BCN Mobile App Plus ABC and BCN Mobile app only
EXPERIMENTALPatients and caregivers randomized to the intervention group will continue to receive care in ABC clinical program and IUHP, and have the BCN software installed on either the caregiver's personal mobile device (assuming it meets minimal technical requirements) or a device provided by the study, per participant preference. A research assistant will orient participants to the device, provide training on the BCN software, and troubleshoot technical issues. Participants will receive daytime technical support by phone, electronic support request through a separate app, or printed and in-app help manuals. Hardware, software, and connectivity check-ups will be provided by study research personnel.
Interventions
The goal of the ABC Clinical Program is to help primary care physicians achieve the standard of care in the diagnosis, evaluation and management of patients with ADRD. The ABC Clinical Program is delivered by an interdisciplinary team led by a care coordinator. The informal caregiver is also enrolled in the program and caregiver burden is assessed and managed. The ABC team collects all relevant data and formulates an individualized care plan in collaboration with the informal caregiver. The care coordinator communicates the team's recommendations to the primary care physician and finalizes a collaborative plan of action. During the next year, the ABC team uses face-to-face and telephone interactions with the patient and caregiver to monitor and modify implementation of the care plan. The goal of IUHP Usual Care is to provide preventive care services to their patients. Older adults are assessed for ADRD during clinic visits and refered to brain care specialty as necessary.
BCN is a mobile application (app) for informal caregivers of patients with Alzheimer's Disease and related dementias (ADRD). The BCN app delivers the following behavioral support: 1. 24/7 psychoeducation and caregiver support on a variety of ADRD related topics, presented as a browse-able library of stories and advice cards or "Notes"; 2. Assessment of informal caregiver status and patients behavioral and psychological symptoms of dementia (BPSD), in the form of the selfadministered HABC Monitor, along with reporting and historical tracking of HABC Monitor scores; 3. Engagement tools, in particular, (i) a toolkit for saving, sorting, creating/editing, and sharing Notes and (ii) a bi-directional messaging tool for communicating with clinicians or trusted others.
Eligibility Criteria
You may qualify if:
- Patient has received a diagnosis of possible or probable Alzheimer's disease and Related Dementia from a physician in the ABC Clinical Program;
- Caregiver is at least 18 years of age and does not have a visual impairment significant enough to interfere with his/her ability to use BCN;
- Both patient and caregiver are community-dwelling in central Indiana; and
- Both patient and caregiver are willing to participate in the ABC Clinical Program (including receiving home visits).
You may not qualify if:
- Either the patient or his/her informal caregiver does not have the ability to communicate in English.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Indiana Universitylead
- National Institute on Aging (NIA)collaborator
Study Sites (2)
Eskenazi Health
Indianapolis, Indiana, 46202, United States
IU Health
Indianapolis, Indiana, 46202, United States
Related Publications (1)
Braly T, Muriathiri D, Brown JC, Taylor BM, Boustani MA, Holden RJ. Technology intervention to support caregiving for Alzheimer's disease (I-CARE): study protocol for a randomized controlled pilot trial. Pilot Feasibility Stud. 2021 Jan 11;7(1):23. doi: 10.1186/s40814-020-00755-2.
PMID: 33431027DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
BCN usage (a primary feasibility outcome) continues to be analyzed and data are not reported. Data are reported from consented informal caregivers only. Caregivers provided data on themselves and the patient. Data on secondary outcomes of Caregiver Burden and Patient Symptom Severity were imputed for all randomized participants. Acute care utilization data combine emergency room (ER) and hospital based admissions.
Results Point of Contact
- Title
- Dr. Richard Holden
- Organization
- Indiana University
Study Officials
- PRINCIPAL INVESTIGATOR
Richard J. Holden, PhD
Indiana University
- PRINCIPAL INVESTIGATOR
Malaz Boustani, MD, MPH
Indiana University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Health & Wellness Design
Study Record Dates
First Submitted
April 12, 2017
First Posted
April 18, 2017
Study Start
November 25, 2019
Primary Completion
July 31, 2021
Study Completion
July 31, 2021
Last Updated
September 19, 2024
Results First Posted
September 19, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- 10 years from the completion of the study
- Access Criteria
- To obtain IDP, requesters must provide a CV or biosketch detailing their institutional affiliation(s), the scientific purpose for the data sharing request, and plans for the safe and secure management of deidentified study data.
Data, or results, will be shared through traditional mechanisms such as peer-reviewed journals and presentations at national meetings. The Enhanced Medical Record - Aging Brain Care (eMR-ABC), the dedicated electronic medical record for the Aging Brain Care (ABC) Clinical Program, was developed with the intent of sharing de-identified data with the scientific community. The Indiana Network for Patient Care (INPC) is a state-wide health information exchange. INPC data is collected for patient care purposes and is not "owned" by Indiana University or the Regenstrief Institute, Inc. - each participating health care system or program retains ownership of their data. At present, Indiana University/Regenstrief Institute scientists do not have the direct authority to share even de-identified patient data. Therefore, any request to use these data for research purposes must be adjudicated on a case-by-case basis.